Executive Director, Program Team Leader, Program and Portfolio Management, Ultragenyx Pharmaceutical Inc., United States
Mark Kryah is an Executive Director at Ultragenyx, leading rare disease development programs. He has been leading global development projects for 20+ years, with extensive international and partnership experience. Mark has been involved with DIA for 20 years, contributing as a presenter/session...
Read More →